Furthermore, we found the classic ferroptosis suppressor gene GPX4 showed upregulated expression in TTs (Additional file 1: Fig. S4h), implying inducing ferroptosis through regulation of GPX4 for tumor therapy might be more effective in TTs than in PTs in ccRCC patients. This evidence concerns the gene GPX4 and neoplasm.